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Abstract
Background: Lysophosphatidic acid (LPA) plays a critical role in airway inflammation through G
protein-coupled LPA receptors (LPA1-3). We have demonstrated that LPA induced cytokine and
lipid mediator release in human bronchial epithelial cells. Here we provide evidence for the role of
LPA and LPA receptors in Th2-dominant airway inflammation.
Methods: 
Wild type, LPA1 heterozygous knockout mice (LPA1
+/-), and LPA2 heterozygous knockout mice
(LPA2
+/-) were sensitized with inactivated Schistosoma mansoni eggs and local antigenic challenge
with Schistosoma mansoni soluble egg Ag (SEA) in the lungs. Bronchoalveolar larvage (BAL) fluids
and lung tissues were collected for analysis of inflammatory responses. Further, tracheal epithelial
cells were isolated and challenged with LPA.
Results: BAL fluids from Schistosoma mansoni egg-sensitized and challenged wild type mice (4 days
of challenge) showed increase of LPA level (~2.8 fold), compared to control mice. LPA2
+/- mice, but
not LPA1
+/- mice, exposed to Schistosoma mansoni egg revealed significantly reduced cell numbers
and eosinophils in BAL fluids, compared to challenged wild type mice. Both LPA2
+/- and LPA1
+/- mice
showed decreases in bronchial goblet cells. LPA2
+/- mice, but not LPA1
+/- mice showed the
decreases in prostaglandin E2 (PGE2) and LPA levels in BAL fluids after SEA challenge. The PGE2
production by LPA was reduced in isolated tracheal epithelial cells from LPA2
+/- mice. These results
suggest that LPA and LPA receptors are involved in Schistosoma mansoni egg-mediated inflammation
and further studies are proposed to understand the role of LPA and LPA receptors in the
inflammatory process.
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Background
Lysophosphatidic acid (LPA) is a naturally occurring bio-
active lysophospholipid and is a component of plasma,
biological fluids, and tissues [1-3]. Many of the biological
responses of LPA such as cell proliferation [4,5], migra-
tion [6,7], and cytokine release [8-10] are mediated by a
family of G-protein coupled receptors (GPCRs). At least
six LPA receptors, LPA1-6, have been cloned and described
in mammals, and the biological effects of LPA are medi-
ated by ligation to specific LPA receptors that are coupled
to heterotrimeric G-protein families, the Gs, Gi, Gq, and
G12/13 [11-17].
The role of LPA and LPA receptors in airway inflammatory
diseases have been studied in vitro and in vivo. LPA is a
potent stimulator of interleukin-8 (IL-8) secretion in pri-
mary cultured human bronchial epithelial cells (HBEpCs)
[8,10], and is a mitogen for airway smooth muscle cells
[18,19]. Intratracheal administration of LPA in mice
increased MIP-2 levels at 3 h and neutrophil infiltration at
6 h [20]. Inhalation of LPA induced histamine release and
enhanced the recruitment eosinophils and neutrophils to
the guinea pig lung alveolar space [21,22]. While these
studies suggest that LPA regulates airway inflammation
via stimulating the release of cytokines and inflammatory
mediators that modulate infiltration of neutrophils and
eosinophils into the airway, others point out that LPA
exhibits anti-inflammatory effects and promotes resolu-
tion of inflammation. In human bronchial epithelial cells,
LPA induced IL-13 decoy receptor, IL-13Rα2 expression
and release, and attenuated IL-13-induced phosphoryla-
tion of STAT6 [9]. Further, LPA enhanced cyclooxygenase-
2 (COX-2) expression and prostaglandin E2 (PGE2)
release in HBEpCs [23] suggesting a protective role in the
innate immunity response and tissue repair process in air-
way inflammation [24,25]. Recently, Fan et al. showed
that intravenous injection with LPA attenuated bacterial
endotoxin-induced plasma TNF-α production and mye-
loperoxidase activity in mouse lung, suggesting an anti-
inflammatory role of LPA in a murine model of acute lung
injury [26]. In addition to its anti-inflammatory effect,
LPA regulated E-cadherin intracellular trafficking and air-
way epithelial barrier integrity and intratracheal post-
treatment with LPA reduced neutrophil influx, protein
leak, and E-cadherin shedding in bronchoalveolar lavage
(BAL) fluids in a murine model of LPS-induced acute lung
injury [27]. These data suggest a protective role of admin-
istrated LPA in airway inflammatory diseases.
In contrast to several in vitro studies on the role of LPA as
a pro- or anti-inflammatory mediator in airway epithelial
and smooth muscle cells [8,10,18-20], there are a few
reports linking LPA levels and LPA receptors to airway or
lung inflammation and injury. We have recently shown
that LPA was constitutively present in BAL fluids from
normal and asthmatic subjects and segmental allergen
challenge increased LPA levels in BAL fluids significantly
[28]. However, the source of LPA and the pathophysiolog-
ical relevance of increased LPA after segmental allergen
challenge to allergic inflammation remain to be eluci-
dated. Similarly, LPA levels in BAL fluids from individuals
with idiopathic pulmonary fibrosis were significantly
higher compared to normal controls [29]. Further, an
increase in LPA levels in BAL fluid following lung injury
was observed in the bleomycin model of pulmonary
fibrosis, and mice lacking LPA1 were protected from fibro-
sis and mortality [29]. These studies suggest a role for LPA
receptors in linking lung injury in the murine bleomycin
model of pulmonary fibrosis.
Asthma is a chronic inflammatory disease of the airways
involving T-lymphocytes and eosinophils infiltration,
mucus overproduction and airway hyper-responsiveness.
Inflammatory mediators including lipid mediators play a
critical role in the pathogenesis of chronic airway diseases
and facilitate the recruitment, activation, and trafficking
of inflammatory cells in the airways. Very little is known
on the physiological consequences of increased LPA levels
and role of LPA receptors in asthma. To address the role of
LPA receptors in Th2-mediated inflammation, we have
used a well described Schistosoma mansoni eggs-sensitized
murine model of allergic airway inflammation [30-32].
Control wild type, LPA1
+/- and LPA2
+/- mice were sensitized
and challenged with Schistosoma mansoni eggs. LPA2
+/-
challenged mice compared to wild type showed decrease
in cell numbers, eosinophils, and positive PAS staining.
Interestingly, only Schistosoma mansoni eggs sensitized and
challenged LPA2
+/-, but not LPA1
+/-, mice showed reduced
PGE2 levels in BAL fluids which correlated with dimin-
ished COX-2 expression in LPA2
+/- mice. Furthermore, air-
way epithelial cells isolated from LPA2
+/- mice exhibited
reduced COX-2 expression and PGE2 release compared to
cells from wild type mice. These results show for the first
time a role for LPA2 in the development of airway inflam-
mation and pathogenesis of asthma.
Materials and methods
Animals
All the mice were bred and housed in a specific pathogen-
free barrier facility maintained by the University of Chi-
cago Animal Resources Center. The studies reported here
conform to the principles outlined by the Animal Welfare
Act and the National Institutes of Health guidelines for
the care and use of animals in biomedical research.
PCR genotyping of LPA1
+/- and LPA2
+/- mice
Extract-N-Amp Tissue PCR kit (Sigma Aldrich, S. Louis)
was utilized for isolating genomic DNA from mouse tail
and amplifying DNA fragments. The primers for LPA1 and
LPA2 knockout mice were described as previous studies
[33,34].Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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Schistosoma mansoni eggs sensitization and challenge
Schistosoma mansoni eggs sensitization and challenge to
induce murine allergic airway disease were described
before [31]. In brief, at day 0, mice (6-8 weeks) were
immunized by i.p. injection of 5,000 inactivated Schisto-
soma mansoni eggs. At day 7, the mice were challenged
with 10 μg of SEA by intratracheal aspiration. The mice
were studied at day 11.
Analyses of BAL fluids
BAL fluids were performed by an intratracheal injection of
1 ml of PBS solution followed by gentle aspiration. The
lavage was repeated twice to recover a total volume of 1.8-
2.0 ml. The lavage was centrifuged and supernatant was
processed for PGE2 or LPA measurement. The percentages
of cell types in BAL fluids were determined by FACS anal-
ysis with cell type-specific markers.
Histology
Lungs were removed from mice and lobes were sectioned
sagitally, embedded in paraffin, cut into 5-μm sections.
Periodic Acid Schiff (PAS) staining were performed by
Pathology Core Facility in The University of Chicago.
Antibodies and flow cytometry
Antibody to mouse CCR3 (clone 831101.111) was
obtained from R&D Systems (Minneapolis, MN). Cells
were fixed with 4% paraformaldehyde for 10 min and
incubated with staining antibodies for 30 min at 4°C. The
samples were washed and analyzed on a FACS LSR-II (Bec-
ton Dickinson).
Isolation of tracheal epithelial cells
Briefly, mice were euthanized and their tracheas were iso-
lated and digested with 0.1% protease (Type XIV, Sigma)
overnight at 4°C. The tracheal cell suspension were trans-
ferred to 15 ml tube and spun at 1500 rpm for 3 min at
4°C and were pooled in BEGM medium (Lonza, Walkers-
ville, MD).
LPA measurement by mass spectrometry
Lipids in BAL were extracted as described before [28]. In
brief, LPA levels were determined using liquid chromatog-
raphy and tandem mass spectrometry (LC) with ABI-4000
Q-TRAP hybrid triple quadrupole/ion trap mass spec-
trometer (MS) coupled with an Agilent 1100 liquid chro-
matography system. Lipids were separated using
methanol/water/HCOOH, 79/20/0.5, v/v, with 5 mM
NH4COOH as solvent A and methanol/acetonitrile/
HCOOH, 59/40/0.5, v/v, with 5 mM NH4COOH as Sol-
vent B. LPA molecular species were analyzed in negative
ionization mode with declustering potential and collision
energy optimized for LPA.
PGE2 measurement
Mouse tracheal epithelial cells grown on 6-well plates
were challenged with LPA for 3 h, medium were collected
and centrifuged at 5,000 × g for 10 min at 4°C. The super-
natant or BAL fluid supernatant were transferred to new
2.0 ml-eppendorf tubes and frozen in -80°C for later anal-
ysis. Measurement of PGE2 levels, as 13, 14-dihydro-15-
keto PGE2, was carried out using a commercial ELISA kit
according to manufacture's instruction.
RNA isolation and Real-time RT-PCR
Total RNA was isolated from cultured mouse tracheal epi-
thelial cells using TRIzol® reagent (Life Technology, Rock-
ville, MD) according to the manufacturer's instructions.
RNA was quantified spectrophotometrically and 1 μg of
RNA was reversed transcripted using cDNA synthesis kit
(Bio-Rad) and Real-time PCR and quantitative PCR were
performed to assess expression of the COX-2, LPA1, LPA2,
LPA3, LPA4, and LPA5 using primers designed based on
mouse mRNA sequences (Table 1.). Amplicon expression
in each sample was normalized to its 18S RNA content.
The relative abundance of target mRNA in each sample
was calculated as 2 raised to the negative of its threshold
cycle value times 106 after being normalized to the abun-
dance of its corresponding 18S, [e.g., 2 -(Target Gene Threshold
Cycle)/2 -(18S Threshold Cycle) × 106].
Western blotting
Equal amounts of protein (20 μg) were subjected to 10%
SDS/PAGE gels, transferred to polyvinylidene difluoride
membranes, blocked with 5% (w/v) BSA in TBST (25 mM
Tris-HCl, pH 7.4, 137 mM NaCl and 0.1% Tween-20) for
1 h and incubated with anti-COX-2 antibody in 5% (w/v)
BSA in TBST for 1-2 h at room temperature. The mem-
branes were washed at least three times with TBST at 15
min intervals and then incubated with a rabbit horserad-
Table 1: Primers for mouse LPA receptors and COX-2
LPA1 Forward: 5'-TCAACCTGGTGACCTTTGTG-3'
Reverse: 5'-GGTCCAGAACTATGCCGAGA-3'
LPA2 Forward: 5'-ATATTCCTGCCGAGATGCTG-3'
Reverse: 5'-AAGCTGAGTAACGGGCAGAC-3'
LPA3 Forward: 5'-ATTGCCTCTGCAACATCTCG-3'
Reverse: 5'-ATGAAGAAGGCCAGGAGGTT-3'
LPA4 Forward: 5'-ACTGCGTTCCTCACCAACAT-3'
Reverse: 5'-CGATCGGAAGGGATAGACAA-3'
LPA5 Forward: 5'-GCTCCAGTGCCCTGACTATC-3'
Reverse: 5'-CAGAGCGTTGAGAGGGAGAC-3'
COX-2 Forward: 5'-CCCCCACAGTCAAAGACACT-3'
Reverse: 5'-GGCACCAGACCAAAGACTTC-3'Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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ish peroxidase-conjugated secondary antibody (1: 3,000)
for 1 h at room temperature. The membrane was devel-
oped with enhanced chemiluminescence detection sys-
tem according to Manufacturer's instructions.
Statistical analysis
All results were subjected to statistical analysis using one-
way ANOVA and, whenever appropriate, analyzed by Stu-
dent-Newman-Keuls test. Data are expressed as means ±
S.D. of triplicate samples from at least three independent
experiments and level of significance was taken to P <
0.05.
Results
Schistosoma mansoni eggs sensitization and challenge 
increases LPA levels in BAL fluids
To investigate the role of LPA receptors in pathogenesis of
asthma, we quantified LPA levels in BAL fluids from con-
trol and SEA-challenged mice. Mice were sensitized by i.p.
injection of 5,000 inactivated Schistosoma mansoni eggs. At
day 7, mice were challenged with or without 10 μg of SEA
by intratracheal aspiration and at day 11, BAL fluids were
collected (Fig. 1) and lipid were extracted and LPA levels
in BAL fluids were measured by LC-MS/MS with C17:0
LPA as an internal standard. As shown in Table 2, LPA was
detectable (~1254.3 ± 357.0 pmole/ml) in control mice
(sensitized with inactivated Schistosoma mansoni eggs but
not SEA challenged), and there was a ~2.8 fold increase in
LPA levels (~3557.9 ± 109.3 pmole/ml) in Schistosoma
mansoni eggs sensitized and challenged mice, compared to
control mice. Unsaturated molecular species of LPA (18:1,
20:4, 22:5, and 22:6) were detected in BAL fluids of con-
trol mice, which increased significantly after SEA chal-
lenge. These results show for the first time, to our
knowledge, increase in LPA during allergic lung inflam-
mation in a murine model of asthma.
Schistosoma mansoni eggs sensitization and challenge-
induced airway inflammation is dependent on LPA1 and 
LPA2
To determine the role of LPA receptors in airway inflam-
mation mediated by Schistosoma mansoni eggs sensitiza-
tion and challenge, we used LPA1 and LPA2 deficient mice,
which were genetically engineered as described earlier
[33,34]. The heterozygous LPA1
+/- and LPA2
+/- mice were
housed and bred at the University of Chicago Animal
Resources Center and described experiments were
approved by the ACIU of the University of Chicago. Gen-
otyping analyses with specific primers confirmed genera-
tion of wild type (+/+), heterozygous (+/-) and
homozygous mice (-/-) from the genetically engineered
LPA1  and LPA2  mice (data not shown). Since LPA1
-/-
showed 50% neonatal lethality and impaired sucking in
neonatal pups, all experiments were carried out with
LPA1
+/- and LPA2
+/- mice to investigate the role of LPA
receptors in Schistosoma mansoni eggs sensitization and
challenge-mediated allergic inflammatory responses. To
determine whether LPA1
+/- and LPA2
+/- mice reduced the
effect of LPA, wild type, LPA1
+/- and LPA2
+/- mice were
intratracheal challenged with 18:1LPA (5 μM in 25 μl
PBS) for 6 h. As shown in Fig. 2, LPA challenge increased
neutrophil infiltration, however, LPA1
+/- and LPA2
+/- mice
reduced LPA-induced neutrophil infiltration in BAL flu-
ids, suggesting that less LPA1 and LPA2 receptors in LPA1
+/
- and LPA2
+/- mice reduce LPA-induced inflammation in
lung and that LPA1
+/- and LPA2
+/- mice are useful models
for investigating role of LPA receptors in lung inflamma-
tory diseases.
Wild type, LPA1
+/-, and LPA2
+/- mice were sensitized with
inactivated Schistosoma mansoni eggs and challenged with
or without SEA for 4 days, BAL fluids and lung tissues were
collected, cell numbers were measured under microscope
and total eosinophils were determined by flow cytometry
using eosinophils specific antibody (anti-CCR3). Consist-
ent with pervious reports [30,32], Schistosoma mansoni
eggs sensitized and challenged wild type mice showed sig-
nificant increase in total cell numbers and eosinophils in
BAL fluids; however, total cell numbers and recruitment
of eosinophils were attenuated in LPA2
+/-, but not LPA1
+/-
mice (Fig. 3). These results suggest a role for LPA2 in influx
of eosinophils into alveolar space during allergic inflam-
matory response.
Airway goblet cell metaplasia and mucus production,
indices of degree of inflammation, are hallmarks of
asthma. Goblet cell metaplasia and mucus production
were determined by PAS staining of histological sections
of lung tissues from Schistosoma mansoni eggs sensitized
and challenged or non-challenged wild type, LPA1
+/-, and
LPA2
+/- mice. As shown in Fig. 4A, PAS positive goblet cells
were higher in Schistosoma mansoni eggs sensitized and
challenged wild type mice, compared to Schistosoma man-
soni eggs sensitized and non-challenged wild type mice
(control mice), whereas significantly less PAS stained gob-
let cells were seen in Schistosoma mansoni eggs sensitized
and challenged LPA1
+/- and LPA2
+/- mice, compared to
Schistosoma mansoni eggs sensitization and challenge induces  murine asthmatic model Figure 1
Schistosoma mansoni eggs sensitization and challenge 
induces murine asthmatic model. At day 0, mice (6-8 
weeks) were immunized by i.p. injection of 5,000 inactivated 
Schistosoma mansoni eggs. At day 7, mice were challenged 
with 10 μg of SEA by intratracheal aspiration. Lung tissues 
and BAL fluids were collected at day 11.Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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Schistosoma mansoni eggs sensitized and challenged wild
type mice. Scoring of the histological sections also con-
firmed a significantly higher percentage of bronchi for
PAS positive stained cells in the sensitized and challenged
control wild type mice compared to LPA1
+/- and LPA2
+/-
mice (Fig. 4B). These results demonstrate that Schistosoma
mansoni eggs sensitized and challenged LPA1
+/- and LPA2
+/
- mice develop reduced goblet cell metaplasia and mucus
production compared to control wild type mice. Together,
these data suggest a role for LPA receptors for optimal
induction of Th2-mediated airway inflammation.
LPA2
+/-, but not LPA1
+/-, mice exhibit reduced LPA and 
PGE2 levels in BAL fluids, and COX-2 expression in lungs 
of Schistosoma mansoni eggs sensitized/challenged mice
Endogenous PGE2 is produced by airway epithelium,
smooth muscle, dendritic cells, and macrophages in
response to allergen challenge [35]. PGE2 has been shown
to be an anti-inflammatory lipid mediator and bron-
chodilator in the airway [24,25]; however, administration
of PGE2 induced various side effects, including cough,
enhanced mucus production, and sensory nerve stimula-
tion [36]. To determine the role of LPA receptors expres-
sion and PGE2 production in response to allergen
challenge, we analyzed PGE2 levels in BAL fluids and
COX-2 expression in lung tissues from Schistosoma man-
soni  eggs sensitized and challenged wild type mice. As
shown in Fig. 5A, PGE2 levels were higher in control wild
type and LPA1
+/-  mice, compared to LPA2
+/-  mice in
response to Schistosoma mansoni eggs sensitization and
challenge.  Schistosoma mansoni eggs sensitization and
challenge increased COX-2 expression in lung tissues of
wild type mice while LPA2
+/- mice showed reduced COX-2
expression (Fig. 5B). Recently, we have shown that LPA
induces COX-2 expression and PGE2 release in human
bronchial epithelial cells [23]. As Schistosoma mansoni eggs
sensitization and challenge increased LPA levels in BAL
fluids (Table 2), we measured LPA levels in BAL fluids
from sensitized and SEA challenged LPA2
+/- mice. Com-
pared to wild type mice, LPA levels in BAL fluids from
Table 2: Quatification of LPA molecular species in BAL fluids
LPA molecular species Wt sensitization only (pmol/ml) Wt sensitization and SEA challenged (pmol/ml)
14:0-LPA 5.6 ± 3.1 14.6 ± 1.2
16:1-LPA 50.4 ± 37.0 160.9 ± 3.7
16:0-LPA 88.4 ± 51.7 253.6 ± 10.8
18:2-LPA 83.9 ± 54.6 274.4 ± 7.0
18:1-LPA 154.3 ± 114.7 517.6 ± 17.9
18:0-LPA 54.9 ± 27.4 153.7 ± 8.0
20:5-LPA 26.7 ± 22.0 95.7 ± 1.9
20:4-LPA 212.9 ± 168.2 739.0 ± 23.1
20:3-LPA 51.7 ± 39.8 165.2 ± 5.5
20:2-LPA 4.7 ± 3.4 14.1 ± 0.8
22:6-LPA 189.4 ± 114.4 548.9 ± 18.1
22:5-LPA 291.6 ± 166.2 576.9 ± 22.2
22:4-LPA 16.8 ± 9.5 41.1 ± 1.5
22:3-LPA 0.7 ± 0.6 1.9 ± 0.5
22:2-LPA 0.2 ± 0.1 0.2 ± 0.1
Total LPA 1254.3 ± 357.0 3557.9 ± 109.3
BAL fluids were collected and lipis were extracted. LPA molecular species were quantified by LC-MS/MS with 17:0LPA as standard.Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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LPA2
+/- mice were decreased after SEA challenge. Together,
these results suggest that increased lung COX-2 expres-
sion, PGE2 and LPA production in BAL fluids by Schisto-
soma mansoni eggs sensitization and challenge is regulated
by LPA2.
LPA2 deficiency on airway epithelial cells leads to reduced 
LPA mediated COX-2 expression and PGE2 release
Having demonstrated a role for LPA2 in Schistosoma. man-
soni eggs-induced COX-2 expression, PGE2 secretion and
airway inflammation, we hypothesized that expression of
LPA2 on airway epithelial cells may be involved in inflam-
matory responses to Schistosoma. mansoni eggs sensitiza-
tion and challenge. To investigate the role of LPA2 in LPA-
induced COX-2 expression and PGE2 production, tra-
cheal epithelial cells were isolated from wild type and
LPA2
+/- mice. Analysis of total RNA for mRNA expression
of LPA receptors by real-time RT-PCR revealed that expres-
sion of LPA2>LPA4>LPA1 ≥ LPA3 in mouse tracheal epithe-
lial cells (Table 3). In contrast to mouse tracheal epithelial
cells, LPA1 and LPA3 were predominantly expressed in
human bronchial epithelial cells [37]. In LPA2
+/- tracheal
epithelial cells, expression of LPA2 mRNA was reduced to
~50%, compared to wild type mice, while there were no
significant changes in expression levels of LPA1 and LPA3
mRNA (Fig. 6A). To determine the role of LPA2in LPA
mediated COX-2 expression and PGE2 release, tracheal
epithelial cells from wild type and LPA2
+/- mice were chal-
lenged with LPA (1 μM) for 3 h, total RNA isolated and
COX-2 mRNA expression determined by Real-time RT-
PCR. LPA stimulated COX-2 mRNA expression in wild
type mouse cells (~13 fold); however, LPA-induced COX-
2 mRNA expression was reduced in LPA2
+/- mouse cells
(~56% of wild type cells) (Fig. 6B). The media, after LPA
challenge, were collected and PGE2 levels were deter-
mined. As shown in Fig. 6C, PGE2 release from LPA2
+/-
mouse tracheal epithelial cells challenged with LPA was
lower as compared to cells from wild type mice [PGE2
(pg/ml)-Wild type: vehicle, 268 ± 29; LPA, 432 ± 47;
LPA2
+/-: vehicle, 283 ± 21; LPA, 374 ± 16]. These results
suggest that a role for LPA2 in LPA-induced COX-2 expres-
sion and PGE2 release from mouse tracheal epithelial
cells.
Discussion
In the present study, we present several novel findings
regarding LPA receptors expression, and its role in infiltra-
tion of eosinophils and lung inflammation in Schistosoma
mansoni eggs sensitized and challenged murine model of
LPA1
+/- and LPA2
+/- mice show reduced neutrophils infiltra- tion to BAL fluids Figure 2
LPA1
+/- and LPA2
+/- mice show reduced neutrophils 
infiltration to BAL fluids. 18:1LPA (5 μM in 25 μl PBS) 
were intratracheally injected to wild type, LPA1
+/-, and LPA2
+/
- mice (n = 4-5) for 6 h. BAL fluids were collected and per-
centage of neutrophils in total cells were examined by Cyt-
ospin.
LPA2
+/- mice exhibit a decrease in cell numbers and eosi- nophils in BAL fluids Figure 3
LPA2
+/- mice exhibit a decrease in cell numbers and 
eosinophils in BAL fluids. After wild type, LPA1
+/-, and 
LPA2
+/- mice (n = 4-6) were challenged with or without Schis-
tosoma mansoni eggs at day 11, as described in Materials and 
Methods, BAL fluids were collected and total cell numbers 
were accounted (A). Eosinophil numbers were examined by 
flow cytometry with antibody to CCR3 (B).Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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LPA1
+/- and LPA2
+/- mice exhibit decreases in goblet cells Figure 4
LPA1
+/- and LPA2
+/- mice exhibit decreases in goblet cells. A) Representative PAS staining sections from Schistosoma 
mansoni eggs unchallenged and challenged wild type, LPA1
+/-, and LPA2
+/- mice (n = 4-6) are shown. B) Percentage of PAS posi-
tive goblet cells in each bronchia (n = 3-5) were calculated.Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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asthma. We provide direct evidence for increased LPA lev-
els in BAL fluids from Schistosoma mansoni eggs sensitized
and challenged mice compared to control mice and a
direct link between LPA2expression and lung inflamma-
tion mediated by Schistosoma mansoni eggs sensitization
and challenge. The pro-inflammatory role of LPA2 is also
evident from reduced PGE2 levels in BAL fluids and COX-
2 expression in lung tissues of LPA2
+/- mice sensitized and
challenged with Schistosoma mansoni eggs compared to
controls. We also demonstrate that airway epithelial cells
isolated from LPA2
+/- mice, compared to cells from wild
type mice, exhibited reduced COX-2 expression and PGE2
release in response to LPA. To the best of our knowledge,
this is the first report demonstrating a functional link
between LPA, LPA2 and lung inflammation in a murine
model of asthma.
Asthma is a Th2-type immune disease of the lung that is
characterized by chronic inflammation, infiltration of
inflammatory cells, reversible obstruction of airway
hyperresponsiveness, mucus hypersecretion by goblet
cells and remodeling of the bronchoalveolar structures.
Th1 and Th2 cytokines play a key role in orchestrating
inflammatory and structural changes of the airway in
asthma by recruiting, activating and promoting inflam-
matory cells into the airway [38-40]. In addition to
cytokines, lipid mediators such as prostaglandins, leukot-
rienes, platelet-activating factor, and lysophospholipids
regulate immune and inflammatory responses in asthma
[41-43]. Many of these lipid mediators exert their biolog-
ical responses via GPCRs. Increasing sphingosine-1-phos-
phate (S1P) levels in circulation offers protection against
lung injury in mice and S1P-receptor 1 (S1P1) hetero-
zygous mice showed enhanced inflammation after LPS
challenge suggesting an anti-inflammatory role of S1P1
[44]. The present study demonstrates the role of LPA and
LPA2, a GPCR, in the pathogenesis of allergic airway
inflammation in Schistosoma mansoni eggs sensitized and
challenged murine model of asthma. LPA1
-/- mice gener-
ated from LPA1
+/- colonies, as compared to LPA2
-/- from
LPA2
+/-, showed 50% neonatal lethality and impaired
suckling, and therefore, we decided to use LPA1
+/- and
LPA2
+/- mice to investigate role of LPA receptors in airway
inflammation. Although LPA1
+/- and LPA2
+/- mice exhib-
ited less neutrophils infiltration, compared to wild type
mice, after LPA challenge (Fig. 2), influx of eosinophils
was lower in LPA2
+/-, but not in LPA1
+/- mice after Schisto-
soma mansoni eggs sensitization and challenge (Fig. 3B).
Both LPA1
+/- and LPA2
+/- mice showed reduced PAS posi-
tive cells in the bronchus compared to wild type after
Schistosoma mansoni eggs sensitization and challenge (Fig.
4) suggesting the potential involvement of LPA1 and LPA2
in activation of goblet cells. These results indicate that
activation of goblet cells are dependent on LPA1 and LPA2,
however, only LPA2 is involved in chemotaxis of eosi-
nophils into alveolar space after Schistosoma mansoni eggs
sensitization and challenge. Our current results on infil-
tration of eosinophils in Schistosoma mansoni eggs sensi-
tized and challenged murine model of asthma are in good
agreement with increased numbers of eosiophils, a char-
acteristic feature of human bronchial asthma, in biopsies
of human lung tissues [40,45]. LPA is constitutively
LPA2
+/- mice exhibit a decrease in PGE2 and LPA levels in  BAL fluids and COX-2 expression in lung tissue Figure 5
LPA2
+/- mice exhibit a decrease in PGE2 and LPA lev-
els in BAL fluids and COX-2 expression in lung tissue. 
BAL fluids and lung tissue were collected from SEA unchal-
lenged and challenged wild type, LPA1
+/-, and LPA2
+/- mice (n 
= 4-6). A) PGE2 levels were measured by ELISA kit. B) Lung 
tissues were subjected to SDS/PAGE gel and COX-2 expres-
sion was determined by Western blotting. Representative 
image were shown. C) LPA levels in BAL fluids were quanti-
fied by LC-MS/MS and changes in LPA levels between wild 
type and SEA challenge mice were normalized to control lev-
els.Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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LPA induces COX-2 expression and PGE2 release through LPA2 Figure 6
LPA induces COX-2 expression and PGE2 release through LPA2. Tracheal epithelial cells from wild type and LPA2
+/- 
mice were isolated as described in Materials and Methods and were cultured in 6-well plates. A) Total RNA was isolated and 
LPA receptors mRNA levels were measured by Real-time RT-PCR. B) Cells were challenged with 18:1LPA (1 μM) for 3 h, and 
COX-2 mRNA levels were measured by Real-time RT-PCR. (C). Cells were challenged with 18:1LPA (1 μM) for 3 h, and 
medium were collected. PGE2 levels in medium were measured by ELISA kit.Respiratory Research 2009, 10:114 http://respiratory-research.com/content/10/1/114
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present in human BAL fluids and increased following
allergic inflammation [28] and in patients with pulmo-
nary fibrosis [29]. Intratracheal administration of LPA
increased eosinophil influx in guinea pigs [22] and treat-
ment of human eosinophils with LPA induced calcium
mobilization, actin reorganization, and chemotaxis
through Gαi-dependent LPA receptors [46]. In the present
study, we found that LPA levels were increased by ~3 fold
following Schistosoma mansoni eggs sensitization and chal-
lenge of wild type, which supports the notion of LPA as a
chemotaxis factor of inflammatory cells in allergic inflam-
mation.
The source of LPA accumulation and mechanism(s) of
LPA generation in the lung after allergic inflammation is
unclear. Our previous studies have demonstrated that acyl
glycerol kinase (AGK) converts monoacylglycerol to LPA
in human bronchial epithelial cells [47]. Further, phos-
pholipase D (PLD) can also contribute to intracellular
LPA generation by providing phosphatidic acid, a sub-
strate for PA specific phospholipase A2 [48,49]. Interest-
ingly, we observed that LPA levels in LPA2
+/- mice were
significantly lower compared to wild type mice after Schis-
tosoma mansoni eggs sensitization and challenge suggest-
ing involvement of LPA2 and potentially other LPA
receptors in regulation of LPA generation in the airway.
The relative contributions of AGK and/or PLD pathways
in LPA generation in response to Schistosoma mansoni eggs
sensitization and challenge are unknown Additionally,
extracellular LPA can be generated by lysoPLD (auto-
taxin), which converts lysophosphatidylcholine (LPC) to
LPA [50]. Not only LPC levels were increased in BAL fluids
of segmental allergen challenged patients [51], there was
an increase in lysoPLD expression in LPS-stimulated
monocytes [52], and stimulation of lysoPLD activity in
asthmatic patients [53]. Thus, increase in LPC levels and
lysoPLD expression and activity may be involved in
enhanced LPA generation during lung inflammation. Fur-
ther studies are needed to establish the potential source(s)
of LPA in BAL fluids and mechanism(s) of LPA generation
during allergic lung inflammation.
In contrast to LPA, there are only a few reports that
describe the role of LPA receptors in lung inflammation,
injury and remodeling. Deletion of LPA1 reduced fibrob-
last recruitment and vascular leak in the bleomycin model
of pulmonary fibrosis [29] while LPA/LPA2 signaling via
αvβ6 integrin-mediated activation of TGF-β has been
implicated in the development of bleomycin-induced
lung fibrosis in mice [54]. Down-regulation of LPA2 by
siRNA attenuated LPA-induced phosphorylation of p38
MAPK/JNK, and IL-8 secretion in human bronchial epi-
thelial cells [37]. Interestingly, Schistosoma mansoni eggs
sensitization and challenge induced COX-2 expression
and PGE2 was significantly attenuated in LPA2
+/-, but not
LPA1
+/-, mice suggesting a potential link between reduced
LPA2 expression and COX2/PGE2 levels. In accordance
with our in vivo results on Schistosoma mansoni eggs medi-
ated COX-2 expression and PGE2 release in mouse lungs,
tracheal epithelial cells from LPA2
+/-  mice exhibited
decreased COX-2 expression and PGE2 release in
response to LPA as compared to cells from wild type mice.
Further, our results with LPA2
+/- mice suggest a role for
LPA2 in the influx of eosinophils and lung inflammation
induced by Schistosoma mansoni eggs sensitization and
challenge suggest a role for LPA signaling via LPA2 in pro-
inflammatory responses.
Conclusion
The present study demonstrates increased LPA levels in
BAL fluids in a murine model of asthma and LPA2 hetero-
zygous knockout mice show reduced Th-2 dominant air-
way inflammatory responses. These results suggest that
endogenous LPA and LPA2 play a critical role in pathogen-
esis of airway inflammatory diseases. Therapeutic target-
ing of LPA2  may be beneficial in reducing allergic
inflammatory responses in airway diseases.
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